Autoimmune hemolytic anemia

From Citizendium - Reading time: 2 min

In hematology, Autoimmune hemolytic anemia (AIHA) is an "acquired hemolytic anemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red blood cells."[1]

Classification[edit]

Diagnosis[edit]

Treatment[edit]

As of 2010, no randomized controlled trials were available.[6] Subsequent studies are below.

Rituximab, a monoclonal antibody, was found to be safe by a systematic review of 21 studies, although only one was a randomized controlled trials.[7]

References[edit]


Licensed under CC BY-SA 3.0 | Source: https://citizendium.org/wiki/Autoimmune_hemolytic_anemia
3 views | Status: cached on August 12 2023 16:38:00
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF